Articles tagged with Negative Regulators
A new study using a novel mouse strain expressing Halo-tagged SOCS1 reveals that the inhibitor needs to exceed a threshold level to suppress GM-CSF and IFN-gamma signaling. The findings emphasize SOCS1's crucial function in modulating cytokine signaling.
Researchers found that investors responded favorably to firms' congressional testimony, particularly those with high regulatory risk and negative tone from committee members. Companies also benefited from their competitors' testimony, albeit to a limited extent.
New research reveals that credit card websites are the most difficult to understand, containing more complex financial terminology than payday loan and personal loan sites. The study measured readability using the Fog Index, finding only payday loans sites meet basic readability standards.
Researchers have discovered that caspase 12 does not act as a dominant-negative regulator of caspase-1 activation and inflammasomes. This finding challenges a stubborn dogma in the field and opens up new avenues for studying caspase 12's role in physiological processes.
A new study in Journal of Consumer Research found that online brand comments impact consumer attitudes differently depending on the tone and number of comments. Promotion-focused individuals react to gain-related information, while prevention-focused ones respond to loss-related information.
Researchers at Monash University have discovered how leptin-resistance develops in overweight and obese individuals. The study reveals that targeting only one of the negative regulators won't be enough to increase leptin-sensitivity in obesity, suggesting that all three regulators might need to be switched off.
Researchers found that increasing Mdmx levels makes mice resistant to radiation but susceptible to oncogene-induced lymphomas. The study reveals the finely tuned balance between tumor suppressor p53 and its negative regulators.
Researchers at Mayo Clinic have discovered a new immune system molecule called B7-H4, which can inhibit T cells and help transplant patients but harm cancer patients. The study's findings may lead to new treatment strategies for autoimmune diseases, organ rejection, and cancer treatment.